Why Is Sportradar Stock Going Up?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock…
Sell
46
GFR Quote, Financials, Valuation and Earnings
Last price:
$5.22
Seasonality move
:
19.25%
Day range:
$5.02 - $5.24
52-week range:
$4.82 - $8.16
Dividend yield:
0%
P/E ratio:
4.35x
P/S ratio:
0.62x
P/B ratio:
0.63x
Volume:
232.5K
Avg. volume:
99.9K
1-year change:
-13.33%
Market cap:
$362.5M
Revenue:
$600.4M
EPS (TTM):
$1.19
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $215.9M | $767.7M | $500.6M | $600.4M | |
| Revenue Growth (YoY) | -- | -- | 255.61% | -34.79% | 19.92% | |
| Cost of Revenues | -- | $104.7M | $373.6M | $293.6M | $321.1M | |
| Gross Profit | -- | $111.2M | $394.1M | $207M | $279.2M | |
| Gross Profit Margin | -- | 51.52% | 51.33% | 41.34% | 46.51% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $21.8M | $60.6M | $57M | $59.7M | |
| Other Inc / (Exp) | -- | $506.1M | -$115.4M | $37.6M | -$35.2M | |
| Operating Expenses | -- | $69.7M | $186.2M | $249.8M | $174.2M | |
| Operating Income | -- | $41.5M | $207.9M | -$42.8M | $105M | |
| Net Interest Expenses | -- | $20M | $58.7M | $81M | $43.2M | |
| EBT. Incl. Unusual Items | -- | $527.6M | $33.8M | -$86.1M | $26.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$67.4M | $14.4M | -$61.9M | |
| Net Income to Company | -- | $527.6M | $101.2M | -$100.5M | $88.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $527.6M | $101.2M | -$100.5M | $88.6M | |
| Basic EPS (Cont. Ops) | -- | $7.69 | $1.47 | -$1.84 | $1.28 | |
| Diluted EPS (Cont. Ops) | -- | $7.69 | $1.47 | -$1.84 | $1.24 | |
| Weighted Average Basic Share | -- | $68.6M | $68.6M | $54.4M | $69.2M | |
| Weighted Average Diluted Share | -- | $68.6M | $68.6M | $54.4M | $71.6M | |
| EBITDA | -- | $569.9M | $144.7M | -$1.3M | $120.9M | |
| EBIT | -- | $547.6M | $92.5M | -$51.5M | $62M | |
| Revenue (Reported) | -- | $215.9M | $767.7M | $500.6M | $600.4M | |
| Operating Income (Reported) | -- | $41.5M | $207.9M | -$42.8M | $105M | |
| Operating Income (Adjusted) | -- | $547.6M | $92.5M | -$51.5M | $62M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $133.1M | $118.8M | $148.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -10.72% | 25.26% | |
| Cost of Revenues | -- | -- | $81.8M | $72.8M | $84.7M | |
| Gross Profit | -- | -- | $51.3M | $46M | $64.1M | |
| Gross Profit Margin | -- | -- | 38.52% | 38.75% | 43.08% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $14.3M | $12.3M | $16.8M | |
| Other Inc / (Exp) | -- | -- | $2.7M | $16.9M | -$13.5M | |
| Operating Expenses | -- | -- | $46.4M | $36M | $47.6M | |
| Operating Income | -- | -- | $4.9M | $10M | $16.5M | |
| Net Interest Expenses | -- | -- | $21.4M | $11.4M | $7.5M | |
| EBT. Incl. Unusual Items | -- | -- | -$13.8M | $15.6M | -$4.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -$64.6M | $19M | -$60.5M | |
| Net Income to Company | -- | -- | -- | -$2.9M | $57.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | $50.8M | -$3.4M | $56M | |
| Basic EPS (Cont. Ops) | -- | -- | $0.74 | $0.11 | $0.81 | |
| Diluted EPS (Cont. Ops) | -- | -- | $0.74 | $0.11 | $0.78 | |
| Weighted Average Basic Share | -- | -- | $68.6M | $68.8M | $69.5M | |
| Weighted Average Diluted Share | -- | -- | $68.6M | $68.8M | $71.8M | |
| EBITDA | -- | -- | $20.7M | -$7.4M | $15.4M | |
| EBIT | -- | -- | $7.6M | -$19.1M | -$4.6M | |
| Revenue (Reported) | -- | -- | $133.1M | $118.8M | $148.8M | |
| Operating Income (Reported) | -- | -- | $4.9M | $10M | $16.5M | |
| Operating Income (Adjusted) | -- | -- | $7.6M | -$19.1M | -$4.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $500.6M | $600.1M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $293.5M | $320.9M | |
| Gross Profit | -- | -- | -- | $207.1M | $279.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $57.1M | $59.6M | |
| Other Inc / (Exp) | -- | -- | $48.7M | $37.4M | -$35.5M | |
| Operating Expenses | -- | -- | -- | $250.2M | $174M | |
| Operating Income | -- | -- | -- | -$43.1M | $105.2M | |
| Net Interest Expenses | -- | -- | $29.1M | $81.2M | $43.2M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$86.8M | $26.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $14.2M | -$60.5M | |
| Net Income to Company | -- | -- | -- | -$100.5M | $88.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$101M | $86.9M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$1.83 | $1.26 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$1.83 | $1.19 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -$1.3M | $120.8M | |
| EBIT | -- | -- | -- | -$51.6M | $62.1M | |
| Revenue (Reported) | -- | -- | -- | $500.6M | $600.1M | |
| Operating Income (Reported) | -- | -- | -- | -$43.1M | $105.2M | |
| Operating Income (Adjusted) | -- | -- | -- | -$51.6M | $62.1M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $293.5M | $500.6M | $600.1M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $152.7M | $293.5M | $320.9M | -- | |
| Gross Profit | -- | $140.9M | $207.1M | $279.2M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $28.2M | $57.1M | $59.6M | -- | |
| Other Inc / (Exp) | -- | $48.7M | $37.4M | -$35.5M | -- | |
| Operating Expenses | -- | $88.8M | $250.2M | $174M | -- | |
| Operating Income | -- | $52.1M | -$43.1M | $105.2M | -- | |
| Net Interest Expenses | -- | $29.1M | $81.2M | $43.2M | -- | |
| EBT. Incl. Unusual Items | -- | $71.7M | -$86.8M | $26.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -$64.6M | $14.2M | -$60.5M | -- | |
| Net Income to Company | -- | -- | -$100.5M | $88.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | $136.3M | -$101M | $86.9M | -- | |
| Basic EPS (Cont. Ops) | -- | $1.98 | -$1.83 | $1.26 | -- | |
| Diluted EPS (Cont. Ops) | -- | $1.98 | -$1.83 | $1.19 | -- | |
| Weighted Average Basic Share | -- | $137.3M | $257.1M | $276.7M | -- | |
| Weighted Average Diluted Share | -- | $137.3M | $257.1M | $284.8M | -- | |
| EBITDA | -- | $125.2M | -$1.3M | $120.8M | -- | |
| EBIT | -- | $100.8M | -$51.6M | $62.1M | -- | |
| Revenue (Reported) | -- | $293.5M | $500.6M | $600.1M | -- | |
| Operating Income (Reported) | -- | $52.1M | -$43.1M | $105.2M | -- | |
| Operating Income (Adjusted) | -- | $100.8M | -$51.6M | $62.1M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $47.7M | $26.1M | $82.6M | $47M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | $27.5M | $16.5M | $16.9M | $33M | |
| Inventory | -- | $12.5M | $10.7M | $10.5M | $10.4M | |
| Prepaid Expenses | -- | $8.2M | $2.9M | $4.3M | $3.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $109.8M | $91M | $123.5M | $100.5M | |
| Property Plant And Equipment | -- | $775.8M | $709.6M | $709.6M | $668.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $885.5M | $865.2M | $884.6M | $876.2M | |
| Accounts Payable | $47.1K | $25.4M | $2.5M | $4.8M | $4.4M | |
| Accrued Expenses | -- | $16.2M | $6.1M | $9.9M | $7.2M | |
| Current Portion Of Long-Term Debt | -- | $86.6M | $46.6M | $33.4M | $173.1M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $72.2K | $4.5M | $4.9M | |
| Other Current Liabilities | -- | $24.1M | $19.9M | $14.4M | $12.9M | |
| Total Current Liabilities | $47.1K | $155.7M | $100.9M | $98.2M | $234M | |
| Long-Term Debt | -- | $168.8M | $140.8M | $250.3M | $56M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $47.1K | $332.7M | $247.9M | $360.7M | $303.8M | |
| Common Stock | -- | $11.8K | $11.1K | $119.5M | $114.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$47.1K | $552.8M | $617.3M | $523.9M | $572.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$47.1K | $552.8M | $617.3M | $523.9M | $572.3M | |
| Total Liabilities and Equity | -- | $885.5M | $865.2M | $884.6M | $876.2M | |
| Cash and Short Terms | -- | $47.7M | $26.1M | $82.6M | $47M | |
| Total Debt | -- | $255.3M | $187.5M | $283.7M | $229.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $26.1M | $82.6M | $47M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $16.5M | $16.9M | $33M | |
| Inventory | -- | -- | $10.7M | $10.5M | $10.4M | |
| Prepaid Expenses | -- | -- | $2.9M | $4.3M | $3.8M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $91M | $123.5M | $100.5M | |
| Property Plant And Equipment | -- | -- | $709.6M | $709.6M | $668.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $865.2M | $884.6M | $876.2M | |
| Accounts Payable | -- | -- | $2.5M | $4.8M | $4.4M | |
| Accrued Expenses | -- | -- | $6.1M | $9.9M | $7.2M | |
| Current Portion Of Long-Term Debt | -- | -- | $46.6M | $33.4M | $173.1M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $72.2K | $4.5M | $4.9M | |
| Other Current Liabilities | -- | -- | $19.9M | $14.4M | $12.9M | |
| Total Current Liabilities | -- | -- | $100.9M | $98.2M | $234M | |
| Long-Term Debt | -- | -- | $140.8M | $250.3M | $56M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $247.9M | $360.7M | $303.8M | |
| Common Stock | -- | -- | $11.1K | $119.5M | $114.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | $617.3M | $523.9M | $572.3M | |
| Total Liabilities and Equity | -- | -- | $865.2M | $884.6M | $876.2M | |
| Cash and Short Terms | -- | -- | $26.1M | $82.6M | $47M | |
| Total Debt | -- | -- | $187.5M | $283.7M | $229.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $527.6M | $101.2M | -$100.5M | $88.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $909.3K | $7.3M | $4.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $25.5M | $126.6M | $64.1M | $105.4M | |
| Capital Expenditures | -- | $3.7M | $30.4M | $24.8M | $63.8M | |
| Cash Acquisitions | -- | -$286.8M | -- | -- | -$3.2M | |
| Cash From Investing | -- | -$268.4M | -$49M | -$9M | -$68.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$44M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $291.6M | -- | $283.2M | -- | |
| Long-Term Debt Repaid | -- | -- | -$95M | -$218.3M | -$66.5M | |
| Repurchase of Common Stock | -- | -- | -- | -$30.7M | -- | |
| Other Financing Activities | -- | -- | -- | -$40M | -$3.1M | |
| Cash From Financing | -- | $291.6M | -$95M | $1.5K | -$69.6M | |
| Beginning Cash (CF) | -- | -- | $46.8M | $26.2M | $79.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $48.7M | -$17.4M | $55.1M | -$33M | |
| Ending Cash (CF) | -- | $48.6M | $27.2M | $81.1M | $49.2M | |
| Levered Free Cash Flow | -- | $21.8M | $96.2M | $39.3M | $41.7M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$2.9M | $57.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -$44.6K | $388.7K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $18.6M | $43.6M | |
| Capital Expenditures | -- | -- | -- | $14.3M | $8.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -$480.9K | |
| Cash From Investing | -- | -- | -- | $14.1M | -$17.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | $269.8K | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -$1.7M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | $1.3M | -$4.6M | |
| Repurchase of Common Stock | -- | -- | -- | $188.4K | -- | |
| Other Financing Activities | -- | -- | -- | $245.2K | $13.9K | |
| Cash From Financing | -- | -- | -- | -$38K | -$4.6M | |
| Beginning Cash (CF) | -- | -- | -- | $49.2M | $27.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -$530K | $244.5K | |
| Additions / Reductions | -- | -- | -- | $32.6M | $21.7M | |
| Ending Cash (CF) | -- | -- | -- | $81.1M | $49.2M | |
| Levered Free Cash Flow | -- | -- | -- | $4.3M | $34.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -$100.5M | $88.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | $7.3M | $4.6M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $64.1M | $105.4M | |
| Capital Expenditures | -- | -- | -- | $24.8M | $63.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -$3.2M | |
| Cash From Investing | -- | -- | -- | -$9M | -$68.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$44M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$218.3M | -$66.5M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | $1.5K | -$69.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $55.1M | -$33M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | $39.3M | $41.7M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$100.5M | $88.6M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | $7.3M | $4.6M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $64.1M | $105.4M | -- | |
| Capital Expenditures | -- | -- | $24.8M | $63.8M | -- | |
| Cash Acquisitions | -- | -- | -- | -$3.2M | -- | |
| Cash From Investing | -- | -- | -$9M | -$68.9M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$44M | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $283.2M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$218.3M | -$66.5M | -- | |
| Repurchase of Common Stock | -- | -- | -$30.7M | -- | -- | |
| Other Financing Activities | -- | -- | -$40M | -$3.1M | -- | |
| Cash From Financing | -- | -- | $1.5K | -$69.6M | -- | |
| Beginning Cash (CF) | -- | -- | $119.3M | $292.6M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -$211.1K | $2.3M | -- | |
| Additions / Reductions | -- | -- | $55.1M | -$33M | -- | |
| Ending Cash (CF) | -- | -- | $174.3M | $260.6M | -- | |
| Levered Free Cash Flow | -- | -- | $39.3M | $41.7M | -- | |
Get GFR Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GFR
Sector
P/E ratio
4.35x
11.16x
PEG ratio
--
0.02x
P/B ratio
0.63x
1.05x
Price / LTM sales
0.62x
0.89x
Growth Metrics
GFR
Sector
Revenue growth
25.26%
-3.73%
Earnings growth
611.17%
-20.35%
Revenue (5-year growth)
--
6.74%
Earnings forecast
$0.24
$0.22
Profitability
GFR
Sector
Profitability FY 2024
$279.2M
$106.1M
Return on invested capital
11.03%
3.74%
Return on assets
9.84%
2.51%
Return on equity
16.57%
5.77%
Earnings Date
Last Earnings Date
Mar
17
Next Earnings Date
May
15
Estimated Next Earnings Date
Jun
16
Balance Sheet
GFR
Sector
Total cash
$47M
$14.9M
Short term investments
--
$3.9M
Total assets
$876.2M
$404.6M
Long term debt
$229.2M
$122.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Roblox Stock a Buy, Sell or Hold?
Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…
Is Shopify a Millionaire Maker?
Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…
Stock Ideas
Buy
55
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 40x
Alerts
Sell
50
RGC alert for Mar 22
Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.
Sell
36
VMI alert for Mar 22
Valmont Industries [VMI] is down 12.54% over the past day.
Buy
61
ALNY alert for Mar 22
Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
